Literature DB >> 19353346

Small airway mucous metaplasia and inflammation in chronic obstructive pulmonary disease.

Victor Kim1, Sheri E Kelemen, Mohammad Abuel-Haija, John P Gaughan, Amir Sharafkaneh, Christopher M Evans, Burton F Dickey, Charalambos C Solomides, Thomas J Rogers, Gerard J Criner.   

Abstract

Mucous metaplasia is an important determinant of small airway obstruction in COPD. Its relationship to small airway inflammation is poorly defined. We analyzed 4 to 6 small airways in 19 COPD patients, GOLD stages 0-4, from lobectomy or lung volume reduction surgery tissue samples. To identify intracellular mucin, periodic acid fluorescent Schiff's (PAFS) stained slides were imaged by fluorescence microscopy. PAFS+ staining area, basement membrane length (L(BM)), epithelial height and area were measured. Mucin was expressed as a percentage of epithelial area. Mucin volume density (MVD) was calculated as PAFS+ area divided by the product of L(BM) and 4/pi. Airways were Giemsa stained for eosinophils and immunostained with antibodies against CD3, CD4, CD8, CD68, and neutrophil elastase (NE), and the number of positively stained cells/mm(2) was quantified in the airway wall. Mucin percent correlated with CD3(+) cell density (r = 0.553, P < 0.0001), and MVD correlated with CD3(+) (r = 0.570, P < 0.0001) and CD8(+) cell density (r = 0.279, P = 0.016). There were weak negative correlations between mucin percent as well as MVD and CD68(+) cell density (r = -0.270, P = 0.02 and r = -0.245, P = 0.036). There was no relationship between epithelial mucin content and CD4(+), NE(+), or eosinophil cell density. CD3(+) and CD8(+) lymphocytic inflammation is related to small airway mucous metaplasia in COPD and may play a causative role in its development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19353346     DOI: 10.1080/15412550802522445

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  23 in total

Review 1.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Large-conductance Ca2+ -activated K+ channel activation by apical P2Y receptor agonists requires hydrocortisone in differentiated airway epithelium.

Authors:  Nathan A Zaidman; Angela Panoskaltsis-Mortari; Scott M O'Grady
Journal:  J Physiol       Date:  2017-06-11       Impact factor: 5.182

3.  A novel nonhuman primate model of cigarette smoke-induced airway disease.

Authors:  Francesca Polverino; Melanie Doyle-Eisele; Jacob McDonald; Julie A Wilder; Christopher Royer; Maria Laucho-Contreras; Emer M Kelly; Miguel Divo; Victor Pinto-Plata; Joe Mauderly; Bartolome R Celli; Yohannes Tesfaigzi; Caroline A Owen
Journal:  Am J Pathol       Date:  2014-12-24       Impact factor: 4.307

4.  The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study.

Authors:  Victor Kim; MeiLan K Han; Gwendolyn B Vance; Barry J Make; John D Newell; John E Hokanson; Craig P Hersh; Douglas Stinson; Edwin K Silverman; Gerard J Criner
Journal:  Chest       Date:  2011-04-07       Impact factor: 9.410

5.  Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.

Authors:  Radhika Joshi; Daniel Valdez; Hosu Kim; Douglas C Eikenburg; Brian J Knoll; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2017-07-17       Impact factor: 3.410

6.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

Review 7.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

8.  β-Blockers have differential effects on the murine asthma phenotype.

Authors:  V J Thanawala; D J Valdez; R Joshi; G S Forkuo; S Parra; B J Knoll; M Bouvier; P Leff; R A Bond
Journal:  Br J Pharmacol       Date:  2015-10-13       Impact factor: 8.739

Review 9.  Targeting mucus hypersecretion: new therapeutic opportunities for COPD?

Authors:  Clémence Martin; Justine Frija-Masson; Pierre-Régis Burgel
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 10.  Dysfunctional lung anatomy and small airways degeneration in COPD.

Authors:  Clémence Martin; Justine Frija; Pierre-Régis Burgel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.